Our customers demand products that yield clear health benefits in everyday use, not just in the controlled setting of clinical trials. We focus our resources on developing medicines and devices that can produce positive real-world outcomes for patients and healthcare providers.
The benefits can range from improving the cost-effectiveness of high-quality care to prolonging lives.
We are also developing services and technologies to augment the benefits of our core products, such as diagnostic tools, smartphone applications to monitor patient health, and programmes to help people lead healthier lifestyles.
Novartis is committed to investing in valuable, innovative technologies and has initiated a number of pilot programmes using remote monitoring devices. These devices may someday provide physicians with a wealth of information to proactively manage the health of patients by monitoring adherence to treatment.
Novartis expects these new technologies to help it remain successful despite a tougher economic environment.